The AI Economy Reshapes the American Dream BlueCollar Skilled Trades Emerge as a Growth Sector SpaceX and OpenAI Public Debuts Could Surpass Berkshire Hathaways Market Value on First Trading Day Taiwan Chip Stocks Rally as Nvidias 150B Spending Plans Boost Sector Mainland China Chip Stocks Slide USTaiwan Arms Sales Pause Acting Navy Chief Cites Iran Operations as New Geopolitical Uncertainty Capital One Spark Cash Plus Targets HighSpending Businesses With 2000 Welcome Bonus Charter Communications Revises Liberty Broadband Buyout Proposal Announces Agreed Terms CBNA Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback SVV Q1 2026 Earnings Narrow EPS Miss Amid Positive Market Response ATOS Q1 2026 Earnings EPS Surprise of 8223 Highlights Cost Management in ClinicalStage Biotech BK Q1 2026 Earnings Strong EPS Surprise of 1326 Amid Stable Market Response The RealReal Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline SBSI Q1 2026 Earnings EPS Beat of 422 Despite Tightening Margin Environment Quanta Services PWR Edges Lower as Sector Pressure Tests Recent Support Levels Accel Entertainment ACEL Holds Steady Near Support as Trading Volume Remains Subdued Opendoor Technologies OPEN Faces Resistance Near 476 as Stock Slips 088 ATRenew RERE Slips 5 as Support Level Comes into Focus Range Capital Acquisition Corp II Warrants RNGTW Flat at 032 as Warrants Trade Near Support US Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Strength Grace Therapeutics Inc GRCE Q1 2026 Earnings Narrowed Loss Beats Expectations Despite Stock Dip Quanterix QTRX Declines 187 as Shares Approach Key Support Cloudflares Q1 Results Beat Expectations Market Reaction Remains Mixed Microbot Medical Inc MBOT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction Stellantis and Jaguar Land Rover Collaborate on US Vehicle Development WMS Q1 2026 Earnings Strong EPS Surprise Despite Stock Decline Fractyl Health Inc GUTS Q1 2026 Earnings EPS Surprise Beats Estimates as Cash Burn Continues Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment Glenmark Pharma and Manappuram Finance Among ShortTerm Opportunities Identified by Religare Broking